TRVX.OL
Price:
$0.59
Market Cap:
$123.47M
Targovax ASA, a clinical stage immuno-oncology company, engages in the development of immune activators to target hard-to-treat solid tumors. Its lead product candidate is ONCOS-102, which is in Phase I/II clinical trials for the treatment of mesothelioma, melanoma, and colorectal cancer. The company is also developing neoantigen vaccines targeting mutant KRAS cancers. In addition, it is developing ONCOS-211 for next generation ONCOS viruses. The company has collaboration agreements with Cancer Research Institute and Ludwig Cancer Research to develop ONCOS-102 for colorectal cancer with peritoneal carcinomatosis; Valo Therapeutics to develop mutant RAS neoantigen coating of ONCOS viruses usi...[Read more]
Industry
Biotechnology
IPO Date
2016-07-08
Stock Exchange
OSL
Ticker
TRVX.OL
According to Targovax ASA’s latest financial reports and current stock price. The company's current Enterprise Value is 123.92M. This represents a change of -36.00% compared to the average of 193.64M of the last 4 quarters.
The mean historical Enterprise Value of Targovax ASA over the last ten years is 369.11M. The current 123.92M Enterprise Value has changed 3.26% with respect to the historical average. Over the past ten years (40 quarters), TRVX.OL's Enterprise Value was at its highest in in the June 2017 quarter at 961.93M. The Enterprise Value was at its lowest in in the December 2017 quarter at -212767000.00.
Average
369.11M
Median
315.64M
Minimum
5.94M
Maximum
858.46M
Discovering the peaks and valleys of Targovax ASA Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 1.99%
Maximum Annual Enterprise Value = 858.46M
Minimum Annual Increase = -7993.57%
Minimum Annual Enterprise Value = 5.94M
Year | Enterprise Value | Change |
---|---|---|
2022 | 206.97M | 176.09% |
2021 | 74.97M | -91.27% |
2020 | 858.46M | 35.37% |
2019 | 634.16M | 64.34% |
2018 | 385.88M | -49.85% |
2017 | 769.48M | 108.11% |
2016 | 369.75M | 198.42% |
2015 | 123.90M | 1.99% |
2014 | 5.94M | -97.73% |
2013 | 261.54M | -7993.57% |
The current Enterprise Value of Targovax ASA (TRVX.OL) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
380.13M
5-year avg
432.09M
10-year avg
369.11M
Targovax ASA’s Enterprise Value is greater than PCI Biotech Holding ASA (31.05M), greater than BerGenBio ASA (82.09M), less than Photocure ASA (1.31B), less than Nordic Nanovector ASA (0), less than IDEX Biometrics ASA (170.76M),
Company | Enterprise Value | Market cap |
---|---|---|
31.05M | $61.59M | |
82.09M | $282.21M | |
1.31B | $1.44B | |
0 | $451.20M | |
170.76M | $153.03M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Targovax ASA using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Targovax ASA or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Targovax ASA's Enterprise Value?
What is the highest Enterprise Value for Targovax ASA (TRVX.OL)?
What is the 3-year average Enterprise Value for Targovax ASA (TRVX.OL)?
What is the 5-year average Enterprise Value for Targovax ASA (TRVX.OL)?
How does the current Enterprise Value for Targovax ASA (TRVX.OL) compare to its historical average?